| Year |
Citation |
Score |
| 2012 |
Kopil CM, Siebert AP, Foskett JK, Neumar RW. Calpain-cleaved type 1 inositol 1,4,5-trisphosphate receptor impairs ER Ca(2+) buffering and causes neurodegeneration in primary cortical neurons. Journal of Neurochemistry. 123: 147-58. PMID 22762283 DOI: 10.1111/J.1471-4159.2012.07859.X |
0.607 |
|
| 2011 |
Kopil CM, Vais H, Cheung KH, Siebert AP, Mak DO, Foskett JK, Neumar RW. Calpain-cleaved type 1 inositol 1,4,5-trisphosphate receptor (InsP(3)R1) has InsP(3)-independent gating and disrupts intracellular Ca(2+) homeostasis. The Journal of Biological Chemistry. 286: 35998-6010. PMID 21859719 DOI: 10.1074/Jbc.M111.254177 |
0.534 |
|
| 2011 |
Che D, Li L, Kopil CM, Liu Z, Guo W, Neumar RW. Impact of therapeutic hypothermia onset and duration on survival, neurologic function, and neurodegeneration after cardiac arrest. Critical Care Medicine. 39: 1423-30. PMID 21610611 DOI: 10.1097/Ccm.0B013E318212020A |
0.538 |
|
| 2010 |
Bevers MB, Ingleton LP, Che D, Cole JT, Li L, Da T, Kopil CM, Cohen AS, Neumar RW. RNAi targeting micro-calpain increases neuron survival and preserves hippocampal function after global brain ischemia. Experimental Neurology. 224: 170-7. PMID 20298691 DOI: 10.1016/J.Expneurol.2010.03.007 |
0.449 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2024 |
Simuni T, Chahine LM, Poston K, Brumm M, Buracchio T, Campbell M, Chowdhury S, Coffey C, Concha-Marambio L, Dam T, DiBiaso P, Foroud T, Frasier M, Gochanour C, Jennings D, ... ... Kopil CM, et al. A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research. The Lancet. Neurology. 23: 178-190. PMID 38267190 DOI: 10.1016/S1474-4422(23)00405-2 |
0.195 |
|
| 2005 |
Kozorovitskiy Y, Gross CG, Kopil C, Battaglia L, McBreen M, Stranahan AM, Gould E. Experience induces structural and biochemical changes in the adult primate brain. Proceedings of the National Academy of Sciences of the United States of America. 102: 17478-82. PMID 16299105 DOI: 10.1073/Pnas.0508817102 |
0.165 |
|
| 2017 |
Eidson LN, Kannarkat GT, Barnum CJ, Chang J, Chung J, Caspell-Garcia C, Taylor P, Mollenhauer B, Schlossmacher MG, Ereshefsky L, Yen M, Kopil C, Frasier M, Marek K, Hertzberg VS, et al. Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease. Journal of Neuroinflammation. 14: 164. PMID 28821274 DOI: 10.1186/S12974-017-0935-1 |
0.081 |
|
| 2021 |
Mantri S, Lepore M, Edison B, Daeschler M, Kopil CM, Marras C, Chahine LM. The Experience of OFF Periods in Parkinson's Disease: Descriptions, Triggers, and Alleviating Factors. Journal of Patient-Centered Research and Reviews. 8: 232-238. PMID 34322575 DOI: 10.17294/2330-0698.1836 |
0.078 |
|
| 2020 |
Dobkin RD, Amondikar N, Kopil C, Caspell-Garcia C, Brown E, Chahine LM, Marras C, Dahodwala N, Mantri S, Standaert DG, Dean M, Shoulson I, Marek K, Katz A, Korell M, et al. Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson's Disease Research: The Fox Insight Cohort Experience. Journal of Parkinson's Disease. 10: 665-675. PMID 32250321 DOI: 10.3233/Jpd-191901 |
0.077 |
|
| 2020 |
Schneider RB, Omberg L, Macklin EA, Daeschler M, Bataille L, Anthwal S, Myers TL, Baloga E, Duquette S, Snyder P, Amodeo K, Tarolli CG, Adams JL, Callahan KF, Gottesman J, ... Kopil CM, et al. Design of a virtual longitudinal observational study in Parkinson's disease (AT-HOME PD). Annals of Clinical and Translational Neurology. PMID 33350601 DOI: 10.1002/acn3.51236 |
0.074 |
|
| 2017 |
Visanji NP, Mollenhauer B, Beach TG, Adler CH, Coffey CS, Kopil CM, Dave KD, Foroud T, Chahine L, Jennings D. The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's disease. Biomarkers in Medicine. PMID 28353371 DOI: 10.2217/Bmm-2016-0366 |
0.073 |
|
| 2016 |
Kang UJ, Goldman JG, Alcalay RN, Xie T, Tuite P, Henchcliffe C, Hogarth P, Amara AW, Frank S, Rudolph A, Casaceli C, Andrews H, Gwinn K, Sutherland M, Kopil C, et al. The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27113479 DOI: 10.1002/Mds.26613 |
0.068 |
|
| 2017 |
Berk S, Greco BL, Biglan K, Kopil CM, Holloway RG, Meunier C, Simuni T. Increasing Efficiency of Recruitment in Early Parkinson's Disease Trials: A Case Study Examination of the STEADY-PD III Trial. Journal of Parkinson's Disease. 7: 685-693. PMID 29103052 DOI: 10.3233/JPD-171199 |
0.067 |
|
| 2021 |
Chahine LM, Edison B, Daeschler M, Siddiqi B, Kopil C, Marras C, Mantri S. Use of Figurative Language by People With Parkinson Disease to Describe "Off" Periods: Clear as Mud. Neurology. Clinical Practice. 11: e462-e471. PMID 34476127 DOI: 10.1212/CPJ.0000000000001059 |
0.065 |
|
| 2020 |
Chahine LM, Edison B, Daeschler M, Mantri S, Kahl S, Rapoport R, Goyle A, Precht C, Kopil C, Marras C. The Most Bothersome Aspects of Periods Reported by Individuals with Parkinson's Disease. Movement Disorders Clinical Practice. 7: 284-292. PMID 32258226 DOI: 10.1002/mdc3.12915 |
0.06 |
|
| 2020 |
Smolensky L, Amondikar N, Crawford K, Neu S, Kopil CM, Daeschler M, Riley L, Brown E, Toga AW, Tanner C. Fox Insight collects online, longitudinal patient-reported outcomes and genetic data on Parkinson's disease. Scientific Data. 7: 67. PMID 32094335 DOI: 10.1038/s41597-020-0401-2 |
0.06 |
|
| 2020 |
Chahine LM, Beach TG, Brumm MC, Adler CH, Coffey CS, Mosovsky S, Caspell-Garcia C, Serrano GE, Munoz DG, White CL, Crary JF, Jennings D, Taylor P, Foroud T, Arnedo V, ... Kopil CM, et al. In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease. Neurology. PMID 32747521 DOI: 10.1212/Wnl.0000000000010404 |
0.059 |
|
| 2018 |
Beach TG, Serrano GE, Kremer T, Canamero M, Dziadek S, Sade H, Derkinderen P, Corbillé AG, Letournel F, Munoz DG, White CL, Schneider J, Crary JF, Sue LI, Adler CH, ... ... Kopil CM, et al. Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4). Journal of Neuropathology and Experimental Neurology. PMID 30107604 DOI: 10.1093/Jnen/Nly056 |
0.059 |
|
| 2018 |
Chen-Plotkin AS, Albin R, Alcalay R, Babcock D, Bajaj V, Bowman D, Buko A, Cedarbaum J, Chelsky D, Cookson MR, Dawson TM, Dewey R, Foroud T, Frasier M, German D, ... ... Kopil C, et al. Finding useful biomarkers for Parkinson's disease. Science Translational Medicine. 10. PMID 30111645 DOI: 10.1126/Scitranslmed.Aam6003 |
0.058 |
|
| 2020 |
Chahine LM, Chin I, Caspell-Garcia C, Standaert DG, Brown E, Smolensky L, Arnedo V, Daeschler D, Riley L, Korell M, Dobkin R, Amondikar N, Gradinscak S, Shoulson I, Dean M, ... ... Kopil C, et al. Comparison of an Online-Only Parkinson's Disease Research Cohort to Cohorts Assessed In Person. Journal of Parkinson's Disease. PMID 31958097 DOI: 10.3233/Jpd-191808 |
0.053 |
|
| 2021 |
Mantri S, Edison B, Alzyoud L, Albert SM, Daeschler M, Kopil C, Marras C, Chahine LM. Knowledge, Responsibilities, and Peer Advice From Care Partners of Patients With Parkinson Disease Psychosis. Frontiers in Neurology. 12: 633645. PMID 33597918 DOI: 10.3389/fneur.2021.633645 |
0.053 |
|
| 2020 |
Chahine LM, Edison B, Mantri S, Kopil C, Marras C. Reply to Comment on: The Most Bothersome Aspects of off Periods Reported by Individuals with Parkinson's Disease. Movement Disorders Clinical Practice. 7: 879-880. PMID 33043094 DOI: 10.1002/mdc3.13021 |
0.052 |
|
| 2021 |
Lin I, Edison B, Mantri S, Albert S, Daeschler M, Kopil C, Marras C, Chahine LM. Triggers and alleviating factors for fatigue in Parkinson's disease. Plos One. 16: e0245285. PMID 33540422 DOI: 10.1371/journal.pone.0245285 |
0.051 |
|
| 2020 |
Mantri S, Klawson E, Albert S, Nabieva K, Lepore M, Kahl S, Daeschler M, Mamikonyan E, Kopil C, Marras C, Chahine LM. Understanding the Lexicon of Fatigue in Parkinson's Disease. Journal of Parkinson's Disease. 10: 1-9. PMID 32568110 DOI: 10.3233/Jpd-202029 |
0.046 |
|
| 2020 |
Yang W, Hamilton JL, Kopil C, Beck JC, Tanner CM, Albin RL, Ray Dorsey E, Dahodwala N, Cintina I, Hogan P, Thompson T. Current and projected future economic burden of Parkinson's disease in the U.S. Npj Parkinson's Disease. 6: 15. PMID 32665974 DOI: 10.1038/S41531-020-0117-1 |
0.041 |
|
| 2019 |
Luo L, Andrews H, Alcalay RN, Poyraz FC, Boehme AK, Goldman JG, Xie T, Tuite P, Henchcliffe C, Hogarth P, Amara AW, Frank S, Sutherland M, Kopil C, Naito A, et al. Motor phenotype classification in moderate to advanced PD in BioFIND study. Parkinsonism & Related Disorders. PMID 31255537 DOI: 10.1016/J.Parkreldis.2019.06.017 |
0.041 |
|
| 2021 |
Cook L, Schulze J, Kopil C, Hastings T, Naito A, Wojcieszek J, Payne K, Alcalay RN, Klein C, Saunders-Pullman R, Simuni T, Foroud T. Genetic Testing for Parkinson Disease: Are We Ready? Neurology. Clinical Practice. 11: 69-77. PMID 33968475 DOI: 10.1212/CPJ.0000000000000831 |
0.04 |
|
| 2021 |
Mantri S, Chahine LM, Nabieva K, Feldman R, Althouse A, Torsney B, Albert SM, Kopil C, Marras C. Demographic Influences on the Relationship Between Fatigue and Quality of Life in Parkinson's Disease. Movement Disorders Clinical Practice. 9: 76-81. PMID 35005068 DOI: 10.1002/mdc3.13360 |
0.033 |
|
| 2021 |
Mantri S, Klawson E, Albert S, Rapoport R, Precht C, Glancey S, Daeschler M, Mamikonyan E, Kopil CM, Marras C, Chahine LM. The experience of care partners of patients with Parkinson's disease psychosis. Plos One. 16: e0248968. PMID 33740031 DOI: 10.1371/journal.pone.0248968 |
0.033 |
|
| 2020 |
Tarolli CG, Zimmerman GA, Goldenthal S, Feldman B, Berk S, Siddiqi B, Kopil CM, Chowdhury S, Biglan KM, Dorsey ER, Adams JL. Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants. Neurology. Clinical Practice. 10: 7-14. PMID 32190415 DOI: 10.1212/CPJ.0000000000000680 |
0.024 |
|
| 2019 |
Vizcarra JA, Sánchez-Ferro Á, Maetzler W, Marsili L, Zavala L, Lang AE, Martinez-Martin P, Mestre TA, Reilmann R, Hausdorff JM, Dorsey ER, Paul SS, Dexheimer JW, Wissel BD, Fuller RLM, ... ... Kopil C, et al. The Parkinson's disease e-diary: Developing a clinical and research tool for the digital age. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30901492 DOI: 10.1002/Mds.27673 |
0.021 |
|
| 2007 |
Solit DB, Ivy SP, Kopil C, Sikorski R, Morris MJ, Slovin SF, Kelly WK, DeLaCruz A, Curley T, Heller G, Larson S, Schwartz L, Egorin MJ, Rosen N, Scher HI. Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 1775-82. PMID 17363532 DOI: 10.1158/1078-0432.CCR-06-1863 |
0.017 |
|
| Hide low-probability matches. |